Tag: EuroPCR 2017
EuroPCR 2017: A “golden era” for valve disease therapies
At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure o...
EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices
New data presented, by Luca Testa (Department of Cardiology, IRCCS Policlinico S. Donato, Milan,...
EuroPCR 2017: No risk factor identified for early stroke events in SURTAVI trial
A review of the neurological complications that occurred after surgical aortic valve r...
EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without increasing ischaemic events
Data from the TOPIC (Timing of platelet inhibition after acute coronary syndrome) study indicate...
EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI
The ARTE study, which was simultaneously presented at EuroPCR (16–19 May, Paris, France) and pub...
EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients is OK but could improve
A pooled patient-level analysis of patients undergoing physiological assessment, with either fra...
EuroPCR 2017: PCI outperforms medical management for treatment of chronic total occlusions
According to a study presented at EuroPCR (16–19 May, Paris, France), compared with optimal medi...
EuroPCR 2017: Micell Technologies’ MiStent non-inferior to Abbot Xience in all-comers RCT
Micell Technologies has announced positive twelve-month data from its DESSOLVE III clinical tria...
EuroPCR 2017: Interventional management of acute heart failure—which device, when and how?
In this PCR video, filmed during EuroPCR (16–19 May, Paris, France), Atul Pathak (Clinique Pasteur, ...
EuroPCR 2017: Study finds no association between implantation technique and risk of scaffold thrombosis
A study—AIDA (Amsterdam investigator-initiated Absorb strategy all-comers trial)—presented at Eu...
EuroPCR 2017: Head-to-head study validates consistent performance of FFR microcatheter
ACIST Medical Systems announced results from the ACIST-FFR study (Assessment of catheter-based i...
EuroPCR 2017: No stent thrombosis with Resolute Onyx drug-eluting stent 2mm
Data for the Resolute Onyx drug-eluting 2mm stent (Medtronic), which were presented at EuroPCR ...
EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve
According to late-breaking trial presented at EuroPCR (16–19 May, Paris, France), a novel self-e...
EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris
Data presented at EuroPCR (16–19 May, Paris, France) indicate that a metallic bioresorbable scaf...
EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year
Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAV...
EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and efficacy to Xience at three years.
Data presented from ABSORB China and ABSORB Japan at EuroPCR (16–19 May, Paris, France) show the...
Teleflex receives FDA 510(k) Clearance for its Arrow AC3 Optimus intra-aortic balloon pump
Teleflex has announced 510(k) clearance from the FDA for its AC3 Optimus intra-aortic balloon pu...
